AchieveCE An Update on Pain Management Drugs for Prescribers
This course provides 2 AMA PRA Category 1 Credit for license renewal and talks about the pharmacology, adverse effects, dosage, and administration of FDA-approved treatments for acute pain like nonopioid analgesics, adjuvant pain medications, migraine medicines, Tramadol/Celecoxib (Seglentis), Bupivacaine/Meloxicam (Zynrelef), IV Meloxicam (Anjeso), and Benzhydrocodone/Acetaminophen (Apadaz).
Cost: $24.00Add to cart
Key Features
-Desktop, Mobile, and Tablet friendly.
-Self-Paced Learning
-No Time Limits or Expiration
-Includes an evaluation and assessment
-Downloadable Certificate
-Credits are reported to CE Broker automatically within 24 hours
Topics Covered
Nonopioid Analgesics
Adjuvant Pain Medications
Bupivacaine/Meloxicam (Zynrelef) for Postsurgical Pain
Tramadol/Celecoxib (Seglentis) for Pain
IV Meloxicam (Anjeso) for Pain
Drugs for Migraine
Benzhydrocodone/Acetaminophen (Apadaz) for Pain
Learning Objectives
At the conclusion of this course, participants will be able to:
1. Explain the current approach to the management of patients with pain.
2. Discuss the nonopioid and opioid pharmacologic options available for treatment of pain and for acute and preventive treatment of migraine and compare them based on their efficacy, dosage and administration, potential adverse effects, drug interactions, and cost.
3. Review the efficacy and safety of the fixed-dose combination of tramadol and celecoxib (Seglentis) for treatment of acute pain and intraoperative administration of the fixed-dose combination of bupivacaine and meloxicam (Zynrelef) for treatment of postsurgical pain.
4. Discuss the efficacy and safety of IV meloxicam (Anjeso) for treatment of moderate to severe pain.
5. Determine the most appropriate therapy given the clinical presentation of an individual patient with pain.
Target Audience
Physician, Physician Assistant, Podiatrist
Additional credit info
This CME activity was planned and produced in accordance with the ACCME Essentials and Policies through the joint providership of The Medical Letter and AchieveCE. The Medical Letter is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Medical Letter ® designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.